Devitra - Company finances
|
EUR
|
2023
From: 2023-03-21
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 7,426 | 4,256 | 7,266 |
| Profit before tax | -1,033 | -95 | 139 |
| Net profit | -1,033 | -95 | 139 |
| Equity | -1,033 | -1,158 | -1,019 |
| Liabilities | 1,134 | 1,864 | 1,151 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 101 | 706 | 132 |
| Total assets | 101 | 706 | 132 |
|
Financial indicators
|
|||
| Revenue change y/y | - | -42.7% | +70.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -1022.8% | -13.5% | 105.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -13.9% | -2.2% | 1.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -13.9% | -2.2% | 1.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Devitra - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-09-02 | 2025-09-30 | 144.90 |
| 2025-07-01 | 2025-09-01 | 72.45 |
| 2025-05-04 | 2025-05-31 | 72.45 |
| 2025-04-01 | 2025-04-30 | 281.85 |
| 2025-03-04 | 2025-03-31 | 209.40 |
| 2025-03-03 | 2025-03-03 | 136.95 |
| 2025-03-01 | 2025-03-02 | 209.40 |
| 2025-02-11 | 2025-02-28 | 136.95 |
| 2025-02-10 | 2025-02-10 | 64.50 |
| 2025-02-01 | 2025-02-09 | 136.95 |
| 2025-01-02 | 2025-01-31 | 64.50 |
| 2024-11-04 | 2024-11-30 | 129.00 |
| 2024-10-01 | 2024-11-03 | 64.50 |
| 2024-09-03 | 2024-09-30 | 129.00 |
| 2024-08-01 | 2024-09-02 | 64.50 |
| 2024-07-02 | 2024-07-31 | 129.00 |
| 2024-06-03 | 2024-07-01 | 64.50 |
| 2024-05-02 | 2024-05-31 | 64.46 |
| 2024-03-01 | 2024-04-30 | 1.96 |
| 2024-02-01 | 2024-02-29 | 127.04 |
| 2024-01-22 | 2024-01-31 | 62.54 |
| 2023-06-01 | 2023-07-31 | 43.50 |
Devitra - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Devitra, MB (code 306278116) is a Small partnership engaged in business and other management consultancy activities. In the latest financial year, 2025, the company generated revenue of €7.3K and returned to profitability with net profit of €139, giving a profit margin of 1.9%. This followed a weaker 2024, when revenue fell to €4.3K and the company posted a €95 loss, after 2023 revenue of €7.4K and a loss of €1.0K. Over the three-year period, revenue weakened in 2024 before recovering in 2025, while profit moved from a larger loss to a small positive result. The balance sheet remains very small: total assets were €132 in 2025, equity was negative at about €1.0K, and liabilities stood at €1.2K. The reported asset turnover of 55.05x indicates that revenue was generated from a very limited asset base. Profitability ratios such as ROE and ROA should be interpreted cautiously because equity and assets are minimal and equity is negative.